Tekcapital plc

Tekcapital plc

TEK · LSE · Financial Services / Asset Management

1.95GBX+0.01 (+0.52%)

Price History

Full chart

Market Stats

Previous Close1.94
Open1.95
Day Range1.83 – 2.00
52-Week Range2.25 – 13.00
Volume1.68M
Market Cap7.60M
P/E (TTM)0.08
Forward P/E18.48
EPS0.33
Dividend Yield0.00%
Beta0.93
50-Day Avg3.43
200-Day Avg6.30

About

Tekcapital plc, together with its subsidiaries, provides technology transfer services to universities and corporate clients in the United Kingdom and the United States. It operates through two segments, Professional Services and Licensing and Investment Activities. The company offers Microsalt, that provides the flavor of salt with half of the sodium; and low-sodium salt and snack food. It also develops and sells smart eyewear under the Lucyd, Nautica, Eddie Bauer, and Reebok brands; provides baked food coating to reduce fat; and portable oxygen concentrators under the Belluscura brand. In addition, the company provides GenIP, a generative artificial intelligence (GenAI) analytic services to companies, research institutions, and venture funds; and Guident, a software platform that enables the remote monitoring and control of autonomous vehicles. Further, the company offers management services. Tekcapital plc was incorporated in 2014 and is based in London, the United Kingdom.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEODr. Clifford Mark Gross MBA, Ph.D.
  • Employees5
  • Headquarters12 New Fetter Lane, London, United Kingdom, EC4A 1JP, UK
  • Websitehttps://www.tekcapital.com

Leadership

  • Dr. Clifford Mark Gross MBA, Ph.D.Executive Chairman, CEO & Member of Science Advisory Board · b. 1957
  • Mr. Konrad DabrowskiChief Financial Officer · b. 1983
  • Mr. Selwyn Lloyd MBAChief Information Officer · b. 1968
  • Mr. Michael S. RosenManaging Director of Academic & Entrepreneurship Training
  • Dr. Jay ShahChief Medical Officer of MicroSalt

Financials

Income Statement

Currency: USD2013-11-302014-11-302015-11-302016-11-302017-11-302018-11-302019-11-302020-11-302021-11-302022-12-312023-12-312024-12-312025-12-31
Total Revenue3.68K210.34K407.42K764.78K7.26M6.83M7.72M9.88M815.99K-9.30M735.26K425.99K285.26K
Growth (%)-+5615.68%+93.70%+87.71%+849.69%-5.92%+12.94%+28.07%-91.74%-1239.90%+107.90%-42.06%-33.03%
Cost of Revenue21.18K0128.78K456.48K692.61K559.63K606.17K458.73K263.92K205.26K314.08K865.01K3.04K
Gross Profit-17.50K210.34K278.64K308.30K6.57M6.27M7.11M9.42M552.07K-9.51M421.18K-439.02K282.22K
Gross Margin-475.43%100.00%68.39%40.31%90.46%91.81%92.15%95.36%67.66%102.21%57.28%-103.06%98.93%
Operating Expense14.06K1.20M1.74M2.87M2.42M1.72M1.59M1.74M1.96M2.73M16.11M-19.60M1.92M
Operating Income-31.56K-993.71K-1.46M-2.56M4.15M4.56M5.52M7.68M-1.41M-12.24M-15.69M19.16M-1.64M
Operating Margin-857.58%-472.44%-358.53%-334.54%57.18%66.67%71.54%77.73%-172.21%131.56%-2133.39%4497.56%-574.10%
EBITDA-1-907.99K-1.43M-2.54M3.81M4.57M5.47M7.53M-1.05M-11.75M-1.31M-1.89M-1.63M
EBITDA Margin-0.03%-431.68%-352.11%-331.89%52.43%66.94%70.93%76.20%-128.70%126.36%-177.83%-443.12%-573.03%
Net Income-31.56K-994.87K-1.46M-2.22M4.49M4.55M5.52M7.68M26.37M-11.77M-15.69M19.16M-17.44M
Net Income Margin-857.58%-472.99%-358.55%-289.63%61.79%66.66%71.50%77.71%3231.50%126.49%-2133.70%4496.87%-6113.05%
R&D-----204.97K173.95K417.57K388.69K399.85K155.09K00
R&D as % of Total Revenue-----3.00%2.25%4.22%47.63%-4.30%21.09%0.00%0.00%
Interest Expense-79.97K709384.44K351.44K18.07K63.67K36755.87M----
Interest Expense % of Total Revenue-38.02%0.17%50.27%4.84%0.26%0.83%0.00%6847.16%----

Balance Sheet

Currency: USD2013-11-302014-11-302015-11-302016-11-302017-11-302018-11-302019-11-302020-11-302021-11-302022-12-312023-12-312024-12-312025-12-31
Total Assets26.10K1.82M3.96M3.62M10.91M16.42M22.96M33.11M68.47M58.15M48.62M70.64M55.98M
Total Liabilities48.28K101.35K242.48K484.82K238.15K286.46K429.25K402.66K406.93K388.61K734.54K571.57K882.57K
Total Equity-22.18K1.72M3.72M2.72M10.68M16.13M22.53M32.71M68.06M57.77M47.89M70.07M55.10M
Cash14.07K1.37M3.14M1.84M1.80M1.17M472.90K538.47K3.54M628.64K620.25K786.29K529.38K
Total Debt15.40K9.41K-----------
Net Debt1.34K-1.36M-3.14M-1.84M-1.80M-1.17M-472.90K-538.47K-3.54M-628.64K-620.25K-786.29K-529.38K

Cash Flow

Currency: USD2013-11-302014-11-302015-11-302016-11-302017-11-302018-11-302019-11-302020-11-302021-11-302022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.28K-1.01M-1.22M-2.38M-2.74M-867.65K-1.40M-950.24K-1.81M-2.56M-1.26M-1.50M-2.16M
Investing Cash Flow--41.80K-165.72K-435.98K-655.21K-739.17K-112.67K-1.35M-3.46M-2.68M-3.59M-1.82M-845.09K
Financing Cash Flow16.09K2.41M3.16M1.65M3.25M1.01M821.69K2.37M8.85M2.30M4.83M3.53M2.71M
Capital Expenditure041.94K166.43K436.30K59.03K45.84K8629502.39K9.16K65.83K21.09K
Free Cash Flow-6.28K-1.06M-1.39M-2.81M-2.80M-913.49K-1.40M-951.19K-1.82M-2.57M-1.33M-1.50M-2.16M
FCF to OCF100.00%104.13%113.60%118.35%102.15%105.28%100.06%100.10%100.13%100.36%105.21%100.00%100.05%

Key Statistics & Ratios

Market Cap7.60M
Enterprise Value7.56M
Trailing P/E0.08
Forward P/E18.48
Price / Sales0.06
Price / Book0.05
EPS0.33
Book Value0.6041
Revenue (TTM)124.15M
Gross Profit (TTM)124.15M
EBITDA122.32M
Profit Margin98.53%
Operating Margin99.53%
Return on Equity87.63%
Return on Assets54.59%
Shares Outstanding281.62M
Shares Float198.15M
Beta0.93
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%